Abstract
Overexpression of C1QTNF6 in Esophageal Cancer and Promotes the Proliferation and Migration of Esophageal Cancer Cells
Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, 1Department of Cardiothoracic Surgery, Suzhou Dushuhu Public Hospital, Suzhou, Jiangsu 215006, China
Correspondence Address:
H. T. Ma, Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China, E-mail: haitaomasoochow@163.com
Esophageal cancer is a common cancer among people in the world. The molecular mechanism of complement C1q tumor necrosis factor related protein 6 in esophageal cancer is still unclear. This article aimed to clarify the role of complement C1q tumor necrosis factor related protein 6 in esophageal cancer. The expression of complement C1q tumor necrosis factor related protein 6 in esophageal cancer tissues was detected using quantitative real-time polymerase chain reaction and Western blot. Furthermore, short hairpin ribonucleic acid was used to knockdown the expression of complement C1q tumor necrosis factor related protein 6 in esophageal cancer cell lines. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, wound healing assays and transwell assays were used to determine the role of complement C1q tumor necrosis factor related protein 6 in esophageal cancer cells. In our research, we found that the expression of complement C1q tumor necrosis factor related protein 6 was up-regulated in esophageal cancer tissues. The increased expression of complement C1q tumor necrosis factor related protein 6 was significantly correlated with tumor stage and lymph node metastasis. The proliferation and migration of esophageal cancer cells were inhibited after complement C1q tumor necrosis factor related protein 6-short hairpin ribonucleic acid transfection in vitro. These results suggested that complement C1q tumor necrosis factor related protein 6 serves as an oncogene and promotes cell proliferation and migration in esophageal cancer. In addition, complement C1q tumor necrosis factor related protein 6 may be a potential therapeutic target for esophageal cancer patients.
